Lab leaders advocate need for Clinical Lab 2.0
It is generally recognized that the clinical lab industry faces a financial squeeze of unprecedented dimensions. Lab test prices are falling steadily and more major cuts are coming to Medicare Part B fees in just 11 months. At the same time, obtaining favorable coverage and reimbursement decisions from payers is becoming tougher. This is why a group of forward-thinking lab leaders is advocating that labs embrace the clinical and financial concept of Clinical Lab 2.0.